Stem cells in mammary development and carcinogenesis: implications for prevention and treatment - PubMed (original) (raw)
Review
Stem cells in mammary development and carcinogenesis: implications for prevention and treatment
Gabriela Dontu et al. Stem Cell Rev. 2005.
Abstract
Recently, substantial progress has been made in the identification and characterization of stem and progenitor cells in the mouse and human mammary gland. Furthermore, there is increasing evidence that a variety of neoplasms, including breast cancer, may result from transformation of normal stem and progenitor cells. Consistent with this model of carcinogenesis, a breast cancer stem cell population, with the phenotype CD24-CD44+ lineage, was recently identified utilizing flow-cytometry based cell sorting and nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice xenografts. As few as 200 cells of this cancer stem cell population were capable of generating tumors in animals, whereas the bulk of the tumor population was tumorigenic only when implanted in high numbers. Like their normal counterparts, the cancer stem cells have the ability to self-renew, driving tumorigenicity and possibly recurrence and metastasis, and have the ability to differentiate, generating the heterogeneity of the tumors. This stem cell model of carcinogenesis has important implications for understanding the basic biology of breast cancer, as well as other cancers. Furthermore, the concept of cancer as a disease of stem and progenitor cells has profound implications for the development of new strategies for cancer prevention and therapy.
Similar articles
- Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS. Liu S, et al. Cancer Res. 2006 Jun 15;66(12):6063-71. doi: 10.1158/0008-5472.CAN-06-0054. Cancer Res. 2006. PMID: 16778178 Free PMC article. - Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
Skrbo N, Hjortland GO, Kristian A, Holm R, Nord S, Prasmickaite L, Engebraaten O, Mælandsmo GM, Sørlie T, Andersen K. Skrbo N, et al. PLoS One. 2014 Nov 24;9(11):e113278. doi: 10.1371/journal.pone.0113278. eCollection 2014. PLoS One. 2014. PMID: 25419568 Free PMC article. - ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G. Ginestier C, et al. Cell Stem Cell. 2007 Nov;1(5):555-67. doi: 10.1016/j.stem.2007.08.014. Cell Stem Cell. 2007. PMID: 18371393 Free PMC article. - Stem cells: their role in breast cancer development and resistance to treatment.
Nicolini A, Ferrari P, Fini M, Borsari V, Fallahi P, Antonelli A, Berti P, Carpi A, Miccoli P. Nicolini A, et al. Curr Pharm Biotechnol. 2011 Feb 1;12(2):196-205. doi: 10.2174/138920111794295657. Curr Pharm Biotechnol. 2011. PMID: 21044007 Review. - Breast cancer, stem/progenitor cells and the estrogen receptor.
Dontu G, El-Ashry D, Wicha MS. Dontu G, et al. Trends Endocrinol Metab. 2004 Jul;15(5):193-7. doi: 10.1016/j.tem.2004.05.011. Trends Endocrinol Metab. 2004. PMID: 15223047 Review.
Cited by
- Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.
Solta A, Ernhofer B, Boettiger K, Megyesfalvi Z, Heeke S, Hoda MA, Lang C, Aigner C, Hirsch FR, Schelch K, Döme B. Solta A, et al. Mol Cancer. 2024 Feb 24;23(1):41. doi: 10.1186/s12943-024-01953-9. Mol Cancer. 2024. PMID: 38395864 Free PMC article. Review. - Identification, Culture and Targeting of Cancer Stem Cells.
Herreros-Pomares A. Herreros-Pomares A. Life (Basel). 2022 Jan 27;12(2):184. doi: 10.3390/life12020184. Life (Basel). 2022. PMID: 35207472 Free PMC article. Review. - CXCL12γ induces human prostate and mammary gland development.
Jung Y, Kim JK, Lee E, Cackowski FC, Decker AM, Krebsbach PH, Taichman RS. Jung Y, et al. Prostate. 2020 Sep;80(13):1145-1156. doi: 10.1002/pros.24043. Epub 2020 Jul 13. Prostate. 2020. PMID: 32659025 Free PMC article. - miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment.
Roscigno G, Cirella A, Affinito A, Quintavalle C, Scognamiglio I, Palma F, Ingenito F, Nuzzo S, De Micco F, Cuccuru A, Thomas R, Condorelli G. Roscigno G, et al. Int J Mol Sci. 2020 Mar 27;21(7):2313. doi: 10.3390/ijms21072313. Int J Mol Sci. 2020. PMID: 32230799 Free PMC article. - p21CIP1 Promotes Mammary Cancer-Initiating Cells via Activation of Wnt/TCF1/CyclinD1 Signaling.
Benard O, Qian X, Liang H, Ren Z, Suyama K, Norton L, Hazan RB. Benard O, et al. Mol Cancer Res. 2019 Jul;17(7):1571-1581. doi: 10.1158/1541-7786.MCR-18-1044. Epub 2019 Apr 9. Mol Cancer Res. 2019. PMID: 30967481 Free PMC article.
References
- Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3311-4 - PubMed
- Science. 2004 Feb 20;303(5661):1198-201 - PubMed
- Nat Genet. 2003 Mar;33(3):416-21 - PubMed
- Cancer Biol Ther. 2004 Sep;3(9):838-44 - PubMed
- Int J Cancer. 2000 Jun 1;86(5):652-9 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous